PHS draft guidelines recommend triple drugs as initial therapy. Public Health Service.
D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009316:National Institutes of Health (U.S.); D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D019562:Viral Load
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors